Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2022
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classificationEmily F Thompson, Jutta Huvila, Amy Jamieson, et al.The Journal of Clinical Investigation|December 22, 2012
Prognostically relevant gene signatures of high-grade serous ovarian carcinomaRoel G W Verhaak, Pablo Tamayo, Ji-Yeon Yang, et al.Nature|December 4, 2014
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolutionPeter Eirew, Adi Steif, Jaswinder Khattra, et al.Plos Medicine|June 4, 2010
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studiesFiona M Blows, Kristy E Driver, Marjanka K Schmidt, et al.Journal of Medical Genetics|May 17, 2015
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriersRachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, et al.International Journal of Cancer|December 1, 2018
A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variantsSehee Kim, Miao Wang, Jonathan P Tyrer, et al.Nature|April 13, 2012
The clonal and mutational evolution spectrum of primary triple-negative breast cancersSohrab P Shah, Andrew Roth, Rodrigo Goya, et al.Oncotarget|October 15, 2017
Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome lociDylan M Glubb, Sharon E Johnatty, Michael C J Quinn, et al.The Journal of Clinical Investigation|October 29, 2024
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancerBrad H Nelson, Phineas Hamilton, Minh Tung Phung, et al.Research Square|November 19, 2025
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinomaDale Garsed, Tibor Zwimpfer, Sian Fereday, et al.Pageof 15